Home > Healthcare > Medical Devices > Diagnostic Devices > Spirometer Market
Spirometer Market size was valued at USD 993.8 million in 2023 and is estimated to grow at 9.6% CAGR from 2024 to 2032, due to the escalating prevalence of respiratory diseases, such as asthma, COPD, and cystic fibrosis. This rise in respiratory conditions is driving the need for spirometry devices for diagnosis and management. The demand for spirometers is likely to expand as they play an increasingly crucial role in monitoring and treating respiratory ailments.
As respiratory health challenges are persisting and healthcare practices are evolving, the product demand will remain high to ensure continued support for diagnosing and managing respiratory diseases. For instance, in December 2023, the WHO European Region announced a rise in respiratory infections, including RSV, COVID-19, and influenza. This surge is underscoring the importance of spirometry devices in diagnosing and managing respiratory illnesses, especially among vulnerable populations, such as young children and at-risk groups.
Report Attribute | Details |
---|---|
Base Year: | 2023 |
Spirometer Market Size in 2023: | USD 993.8 Million |
Forecast Period: | 2024 - 2032 |
Forecast Period 2024 - 2032 CAGR: | 9.6% |
2032 Value Projection: | USD 2.2 Billion |
Historical Data for: | 2018 - 2023 |
No. of Pages: | 130 |
Tables, Charts & Figures: | 266 |
Segments covered: | Product, Technology, Application, End-use, and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|
The market is expected to further expand due to the increasing popularity of home healthcare and self-monitoring. This factor is driving the development of user-friendly and affordable spirometry devices for home use as they are more accessible, allowing individuals to monitor their respiratory health from the comfort of their own homes. Lastly, advancements in technology are making spirometers even more user-friendly and cost-effective to extend their reach and empower individuals to take proactive measures for their respiratory well-being.
For instance, in January 2024, the FDA granted 510(k) clearance to NuvoAir for its Air Next spirometer's in-home use. This device enables individuals to perform lung function tests at home by facilitating continuous monitoring for conditions, such as COPD, asthma, and ALS while enhancing accessibility and convenience for patients managing respiratory health.
In addition, the demand for spirometry testing is increasing due to the growing emphasis on preventive healthcare measures. Routine health check-ups are incorporated with spirometry, particularly for individuals with a family history of respiratory diseases or exposure to environmental pollutants. The strong focus on the early detection and management of respiratory conditions along with the rise in proactive healthcare strategies for individuals at risk will favor the market growth.
However, the high initial costs for advanced models will hinder the widespread product adoption to some extent. The lack of skilled professionals for accurate interpretation is also posing barriers to effective utilization. On the other side, the ongoing efforts in training and cost reduction initiatives will gradually mitigate these challenges to facilitate broader accessibility and usage.